News Detail
New Delhi, 12 Feb 2025: India's pharma market saw 3,151 new brands launched over the past 12 months, with AstraZeneca's cancer drug Enhertu emerging the highest selling brand indicating a significant rise in cancer incidence in India.
AstraZeneca India's breast cancer ......
View Details
Source : Economic Times
pharmaceutical brands in India
astrazeneca
sun pharma
AstraZeneca
trastuzumab deruxtecan
HER2-positive cancer treatment
breast cancer medication
India pharmaceutical market
Enhertu
cancer drug sales
Related News
- ‘Sodium Phosphates Enema BP,’ claimed to treat ‘Convulsions’ seized (12-02-2025)
- Substandard Medicines issue raised in Rajya Sabha (12-02-2025)
- Enhancing chemotherapy efficacy; targeting drug resistance with novel molecules: Study (12-02-2025)
- FDA slaps China-based API makers with warning letters outlining quality, testing shortfalls (12-02-2025)
- Falsely manufactured RedFer-XT Tablets seized in for violating drug regulations (12-02-2025)
- Health ministry issues final notification on extension of revised Schedule M deadline for MSMEs (12-02-2025)
- Anticancer Drug Pharmacokinetics may differ by Sex (12-02-2025)
- Biovet’s BIOLUMPIVAXIN® vaccine for Lumpy Skin disease receives CDSCO License (12-02-2025)
- Drug Trafficking Network busted on Amritsar-Jamnagar Expressway; Three Individuals, Including a Woman, Arrested (12-02-2025)
- NPPA fixes retail price of 42 formulations, revise prices based on review orders (11-02-2025)